On March 7, 2024, the Board of Directors of Pulmatrix, Inc. (the “Company”) approved the termination of the Company’s Chief Medical Officer (“CMO”), Dr. Margaret Wasilewski’s, employment with the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Dr. Margaret Wasilewski was terminated as Chief Medical Officer at Pulmatrix, Inc..
Action
terminated
Role
Chief Medical Officer
Exact text from the filing
On March 7, 2024, the Board of Directors of Pulmatrix, Inc. (the “Company”) approved the termination of the Company’s Chief Medical Officer (“CMO”), Dr. Margaret Wasilewski’s, employment with the Company.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.